Summary: Antiepileptic drugs (AEDs) vary in their efficacy against generalized tonic-clonic, myoclonic, and a b sence seizures, suggesting different mechanisms of action. Phenytoin (PHT), carbamazepine (CBZ), and valproate (VPA) reduced the ability of mouse central neurons to sustain high-frequency repetitive firing of action potentials (SRF) at therapeutic free serum concentrations. Phenobarbital (PB) and the benzodiazepines (BZDs), diazepam (DZP), clonazepam (CZP), and lorazepam (UP), also reduced SRF, but only at supratherapeutic free serum concentrations achieved in treatment of generalized tonicclonic status epilepticus. These AEDs interact with sodium channels to slow the rate of recovery of the channels from inactivation. The BZDs and PB enhanced 7-aminobutyric acid (GABA) responses evoked on mouse central neurons by binding to two different sites on the GABA,, receptor channel. BZDs increased the frequency of GABA receptor channel openings. In contrast, barbiturates increased the open duration of these channels. VPA enhanced brain GABA concentration and may enhance release of GABA from nerve terminals. Ethosuximide (ESM) reduced a small transient calcium current which has been shown to be involved in slow rhythmic firing of certain neurons. Reduction of SRF, enhancement of GABA-ergic inhibition, and reduction of calcium current may be, in part, the bases for AED action against generalized tonic-clonic, myoclonic, and absence seizures, respectively. Key Words: An-
ticonvulsants-Neuropharmacology-Membrane
potentials-Calcium.
Despite substantial interest in developing safer and more efficacious antiepileptic drugs (AEDs), six classes of AEDs, which have been in use for 15-75 years, continue to be the primary drugs used to treat patients with epilepsy. The AED classes are hydantoins [phenytoin (PHT) (Table 1) . PHT and CBZ are administered exclusively for generalized tonic-clonic and partial seizures, whereas ESM is used exclusively against generalized absence seizures. VPA, barbiturates, and BZDs have a broader range of action, but drugs from the latter two classes have use limited by sedation and development of tolerance. The different selectivity of the AEDs suggests multiple mechanisms of action.
Consistent with this view, several neuronal properties have been shown to be regulated by AEDs (Mac- donald and McLean, 1986) . AEDs reduce sustained, high-frequency, repetitive firing of action potentials (SRF), enhance GABAergic inhibition, and reduce calcium currents. In the sections below, these three mechanisms will be discussed.
EFFECI'S OF AEDs ON SRF
AEDs have been shown to alter many membrane properties of neurons and axons (Esplin, 1957; Raines and Standaert, 1966; Hershkowitz and Raines, 1978; Macdonald and McLean, 1986) . However, to be an AED mechanism of action, the membrane effects must be produced at CSF and plasma concentrations free of protein binding in ambulatory patients. A direct membrane effect produced only at toxic free-plasma levels is unlikely to be a relevant AED mechanism of action. PHT, CBZ, VPA, antiep ileptic BZDs, PB, and PRM blocked SRF in verte- ---NO efficacy.
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brate cortical and spinal cord neurons in cell culture (McLean and Macdonald, 1983; Macdonald and McLean, 1986) . However, only PHT, CBZ, and VPA reduced SRF ( Fig. 1) at therapeutic free-serum concentrations (Table 2 ).
The AED-induced block of SRF has several important properties. First, the block is voltagedependent R. = minimum therapeutic free-serum concentrations against generalized tonic-clonic and partial seizures.
Other drug abbreviations as in Table I. maintained membrane hyperpolarization and increased by maintained membrane depolarization. Second, the effect of the AEDs is usedependent. Following membrane depolarization, most neurons fire a train of action potentials with varying degrees of PHT 81cM CBZ 8.5uM spike frequency adaptation. However, in the presence of an AED, the action potentials within the train are progressively altered. The initial action potential is unaffected, but each subsequent one has a smaller amplitude and a lower rate of rise. Eventually, firing of action potentials fails during the depolarization. Third, the effect of the AEDs is time dependent. After SRF has been blocked, single evoked action potentials will have reduced the amplitude and the rate of rise for several hundred msec. Thus, removing the effect of the AED takes several hundred ms. PHT and CBZ reduced the amplitude of sodiumdependent action potentials by increasing the voltage dependency of steady-state inactivation and by reducing the rate of recovery of sodium channels from inactivation (Courtney and Etter, 1983; McLean and Macdonald, 1983; Matsuki et al., 1984; Willow et al., 1985; McLean and Macdonald, 1986b) . PHT, CBZ, PB, and DZP all inhibited the binding of [HJbatrachotoxin A 20-a-benzoate (BTX-B) to sodium channels and reduced batrachotoxin-stimulated 22Na influx in brain synaptic terminals (Willow et al., 1984) . BTX-B is a toxin that binds to sodium channels at a site related to activation of sodium channel ion flux (Willow and Catterall, 1982) .
The effects of the AEDs on sodium channels are similar to those of local anesthetic drugs (Strichartz, 1973; Courtney, 1975; Hille, 1977; Khodorov, 1981) . The action of these drugs has been interpreted using the modulated-receptor hypothesis (Hille, 1977; Courtney and Etter, 1983) . The sodium channel has been demonstrated to exist in three main conformations: a resting (R) or activatable state, an open (0) or conducting state, and an inactive (I) or nonactivatable state (Fig. 2) . Under normal circumstances, when membrane potential is large and negative, most of the sodium channels are in the activatable state. the sodium channels open, depending upon the level of the membrane depolarization. With progressive depolarization, some channels are converted to the inactive state; membrane depolarization now will open fewer channels. If the membrane is strongly depolarized, all channels may be in the inactive state, and no channels will open. To remove channel inactivation, the membrane must be hyperpolarized again to a large negative voltage.
The modulated-receptor hypothesis postulates that drugs bind to the different forms of these channels with Merent affinity. The AEDs likely bind to the inactive form of the channel (Fig. 2) . Therefore, when a neuron has a large negative membrane potential, all the channels are closed and are not bound with high affinity by the AEDs. In contrast, when the cell is depolarized, a fraction of the channels are inactive, allowing equilibrium to shift toward the bound, inae tive conformation of the channel. In such a model, AEDs can produce t i m e , voltage-, and usedependent block of sodium-dependent action potentials because the fraction of inactive channels is increased by membrane depolarization and by mpetitive firing. Since the drug that is bound to the inactive channels takes time to dissociate, the block is time dependent. Therefore, it is likely that AEDs block SRF of sodium action potentials by selectively binding to the inactive form of the sodium channel.
While the apparent mechanism of action of VPA is similar to that of PHT and CBZ (McLean and Ma0 donald, 1986a), VPA has not been shown to bind to the BTX-B binding site on sodium channels (Willow and Catterall, 1982) or to block batrachotoxin-stimulated 22Na influx in brain synaptic terminals (Willow et al., 1984) . Thus, VPA may bind to a different Site on sodium channels than PHT and CBZ.
Barbiturates, PRM, and BZDs also block SRF, but only at supratherapeutic concentrations (Macdonald and McLean, 1986; McLean and Macdonald, 1988) .
However, barbiturates and BZDs block SRF at concentrations that are achieved in the treatment of generalized tonic-clonic status epilepticus (Table 2) .
Thus, it is likely that both PB and DZP block SRF at concentrations achieved in the treatment of generalized tonic-clonic status epilepticus and that this effm may contribute to their antiepileptic action in this clinical setting.
In contrast to PHT, CBZ, VPA, BZDs, PB, and PRM, the antiabsence drug ESM did not block SRF (Macdonald and McLean, 1986) , reduce BTX-B binding (Willow and Catterall, 1982) , or reduce batrachotoxin-stimulated "Na influx in brain synaptic terminals (Willow et al., 1984 
EFFECTS OF AEDs ON INHIBITORY MECHANISMS
Synaptic inhibition is an important mechanism for regulation of central nervous system excitability. Enhancement of inhibition, therefore, would be an effective way to decrease abnormal excitability. Inhibition in the nervous system is mediated by a number of neurotransmitters and their corresponding receptors. Rapid inhibition is mediated primarily by amino acid neurotransmitters, including y-aminobutyric acid (GABA) and glycine acting on postsynaptic GABA (GABAA) receptors and glycine receptors, respectively. Rapid forms of inhibition mediated by glycine and GABA receptors are produced by activation of neurotransmitter receptors where the proteins forming the receptor also form the channel (Grenningloh et al., 1987; Schofield et al., 1987) .
The only form of inhibition clearly shown to be regulated by AEDs is GABAergic inhibition. Both barbiturates and BZDs enhance postsynaptic GABAreceptor current (Fig. 3) . The GABA receptor has been shown to be an oligomeric complex consisting of at least two binding sites for GABA, allosteric regulatory binding sites for BZDs and j3-carbolines, picrotoxin-like convulsant drugs and barbiturates, and a chloride channel (Polc et al., 1982; Tallman and Gallager, 1985; Olsen and Venter, 1986) . The receptor appears to be formed from two peptide subunits, an a-chain and a &chain, with a stoiciometry of a2P2 (Schofield et al., 1987) , and there are at least three different isoforms of a-chain (Levitan et al., 1988) . The GABA binding site is on the &chain, and the BZD binding site is on the a-chain. Each peptide chain spans the membrane at least four times, having four membrane or M regions. The juxtaposition of the M regions is thought to form the chloride ion channel opened by GABA binding. A series of positive charges around the extracellular portion of the M regions are presumably involved in regulating the negatively charged chloride ion entry and repelling the positively charged cations. Barbiturates and BZDs bind to specific allosteric regulatory binding sites on the GABA receptor. BZDs have been shown to enhance the binding of GABA to its receptor (Meiners and Salama, 1982; Skenitt et al., 1982) and to enhance GABA-receptor current (Choi et al., 1977; Macdonald and Barker, 1978) . Phenobarbital, however, does not enhance the binding of GABA to its receptor (Olsen and Snowman, 1982) but does enhance GABA-receptor current (Macdonald and Barker, 1978) . The BZDs DZP, CZP, and NZP all enhance GABA-receptor current at low nanomolar concentrations that are achieved in CSF and plasma unbound to plasma proteins (Skerritt and Macdonald, 1984) (Table 3) . Similarly, PB enhances GABA-receptor current at a concentration achieved in ambulatory patients in CSF and plasma unbound to plasma proteins (Schulz and Macdonald, 1981) (Table 3) .
While both BZDs and barbiturates enhance GABA-receptor current, they do so by different mechanisms (Study and Barker, 1981; . When GABA binds to its receptor and gates open the chloride ion channel, the channel opens and closes rapidly, forming bursts of openings interrupted by brief closures (Hamill et al., 1983; Macdonald et al., 1989) . This bursting behavior of GABA-receptor currents appears to be a general property of neurotransmitter-gated receptor channels (Colquhoun and Sakmann, 1985) . BZDs increase the frequency of Occurrence of these bursting GABA-receptor currents (Bormann, 1988; Twyman et al., 1988 Twyman et al., , 1989 . Barbiturates, however, do not, but instead, appear to modify the stability of individual openings (Twyman et al., 1988 . The GABAreceptor bursts are still present, but the openings within the bursts are prolonged, and there is more current flow per burst (Fig. 4) . Thus, BZDs and barbiturates enhance GABA-receptor currents by binding to different sites and by regulating different properties of the GABA-receptor channel (Fig. 5) .
In addition to enhancing postsynaptic GABA-receptor-channel properties, drugs that intensify the release of GABA are thought also to have antiepileptic properties. The most notable such drug is VPA. VPA has been demonstrated to block GABA catabolism by inhibiting succinic simialdehyde dehydrogenase (Chapman et al., 1982) and by increasing brain GABA levels, possibly selectively, in synaptic termi- . bursts with staMe long openings were of the same duration but more frequent. This resulted in more GABA-receptor current. In the presence of (PB) (A4. bursts were prolonged and consisted of longer singlechannel openings. 6: In a simplified burst kinetic model for the GABA-receptor-channel complex, 2 molecules of GABA bind to the receptor to gate open the chloride channel into bursts. DZP enhanced GABA binding affinity to increased burst frequency without altering individual GABA-receptor bursts. PB altered the GABA-re--or burrts by prolonging the time spent in the open state. This site of action may be at or near the channel to modify the proparties of channel gating. (From Twyman et al., 1989.) nal pools (Larsson et al., 1986) . While still unproven (Chapman et al., 1982) , it has been proposed that the increased brain GABA levels result in increased GABA release (Gram et al., 1988) and, therefore, an antiepileptic action.
EFFECTS OF AEDs ON CALCIUM CURRENTS
In addition to effects on sodium channels, clinically used AEDs have demonstrated effects on calcium channels (Macdonald and McLean, 1986) . Calcium enters neurons through three different voltage-dependent calcium channels (Nowycky, et al., 1985) , designated L, N, and T (Fig. 6) . These calcium channels differ in their voltage dependency for activation and inactivation, rate of inactivation, and individual channel conductance. In addition, they have a different agonist and antagonist pharmacology. L-channel conductance is large, and L-current is long-lasting and slowly inactivating. T-channel conductance is small, and T-currents are transient and inactivate rapidly. N-channel conductance is intermediate in magnitude, and N-current inactivates at a rate between that of the T-and Lcurrents.
PHT, barbiturates, and BZDs have been demonstrated to reduce calcium influx into synaptic terminals (Blaustein and Ector, 1975; Ondrusek et al., 1979; Leslie et al., 1980; Ferrendelli and DanielsMcQueen, 1982) and to block presynaptic release of neurotransmitter (Somjen, 1963; Kalant and Grose, 1967; Richter and Waller, 1977; Yarri et al., 1977; Mitchell and Martin, 1978) at supratherapeutic concentrations. The barbiturates PB and pentobarbital block both L-and N-currents, without affecting Tcalcium current, at anesthetic but not free-serum AED concentrations Macdonald, 1987, 1988) (Fig. 6) . Similarly, PHT (McLean and Macdonald, 1983) and DZP (Skemtt et al., 1984) have been demonstrated to block calcium currents at supratherapeutic AED concentrations.
In contrast, ESM and the tnmethadione metabo-
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lite, dimethadione, have recently been shown to affect T-calcium currents in thalamic neurons (Coulter et al., 1988) and in primary afferent neurons (Gross et al., 1989) at therapeutically relevant concentrations ( Fig. 7) ( Table 4) . It has been proposed that T-calcium currents are important pacemaker currents in thalamic neurons and that these currents may be responsible, in part, for the 3-Hz rhythm seen in the electroencephalogram of patients with generalized absence seizures (Coulter et al., 1988) . Blockade of T-calcium currents by ESM or trimethadione, then, would disrupt the slow rhythmic firing of thalamic neurons as well as the spike and wave discharge. However, VPA and CZP did not alter T-calcium currents in primary afferent neurons (Gross et al., 1989) . Thus, it is possible that this effect on T-calcium currents may underlie the effect of ESM and trimethadione on generalized absence seizures but not the effect of VPA and the BZDs.
SUMMARY
AEDs can be divided mechanistically into at least three classes (Table 5 ) based on ability to black SRF by enhancing sodium-channel inactivation, to enhance GABAergic inhibition, and to block slow, pacemaker-driven, repetitive firing by blocking T-calcium current. AEDs such as PHT however, they do not alter T-calcium current (Type I1 AEDs). ESM and dimethadione, on the other hand, have no effect on either postsynaptic GABA responses or SRF, but they block T-calcium currents (Type 111 AEDs). These results further suggest that the ability of a Type I AED to block generalized tonic-clonic seizures and some forms of partial seizures may correlate with the ability of the AED to block SRF. On the other Table I dium-channel function.
which was effective against generalized absence seizures. 
